LAWLOR, Rita Teresa
 Distribuzione geografica
Continente #
NA - Nord America 10.496
EU - Europa 10.312
AS - Asia 8.108
SA - Sud America 1.334
Continente sconosciuto - Info sul continente non disponibili 524
AF - Africa 345
OC - Oceania 62
Totale 31.181
Nazione #
US - Stati Uniti d'America 10.127
RU - Federazione Russa 4.069
SG - Singapore 3.015
CN - Cina 2.103
IT - Italia 1.881
GB - Regno Unito 1.480
BR - Brasile 1.060
HK - Hong Kong 808
VN - Vietnam 741
DE - Germania 600
IE - Irlanda 474
SE - Svezia 421
FR - Francia 415
BD - Bangladesh 400
KR - Corea 248
FI - Finlandia 243
CA - Canada 189
NL - Olanda 173
IN - India 167
JP - Giappone 96
ES - Italia 92
MX - Messico 92
UA - Ucraina 91
AR - Argentina 85
AT - Austria 81
TR - Turchia 74
ID - Indonesia 71
PL - Polonia 60
ZA - Sudafrica 60
NG - Nigeria 58
AU - Australia 54
IQ - Iraq 52
JO - Giordania 52
TG - Togo 50
EC - Ecuador 48
PK - Pakistan 44
BE - Belgio 42
VE - Venezuela 38
CO - Colombia 35
BJ - Benin 32
SA - Arabia Saudita 31
MA - Marocco 30
UZ - Uzbekistan 30
KE - Kenya 28
CL - Cile 25
IR - Iran 23
LT - Lituania 22
CH - Svizzera 21
PY - Paraguay 20
CZ - Repubblica Ceca 19
PH - Filippine 17
MY - Malesia 16
BF - Burkina Faso 15
EG - Egitto 15
TN - Tunisia 15
CR - Costa Rica 13
ET - Etiopia 13
JM - Giamaica 12
AZ - Azerbaigian 11
HR - Croazia 11
IL - Israele 11
KG - Kirghizistan 11
PT - Portogallo 11
RO - Romania 11
AE - Emirati Arabi Uniti 10
BG - Bulgaria 10
LV - Lettonia 10
NP - Nepal 10
RS - Serbia 10
GR - Grecia 9
HN - Honduras 9
OM - Oman 9
DZ - Algeria 8
SK - Slovacchia (Repubblica Slovacca) 8
SV - El Salvador 8
AM - Armenia 7
BO - Bolivia 7
DO - Repubblica Dominicana 7
NI - Nicaragua 7
PA - Panama 7
PE - Perù 7
SI - Slovenia 7
TH - Thailandia 7
TT - Trinidad e Tobago 7
TW - Taiwan 7
UY - Uruguay 7
AL - Albania 6
GT - Guatemala 6
KZ - Kazakistan 6
NZ - Nuova Zelanda 6
LB - Libano 5
MD - Moldavia 5
SY - Repubblica araba siriana 5
BB - Barbados 4
BY - Bielorussia 4
CY - Cipro 4
HU - Ungheria 4
LU - Lussemburgo 4
NO - Norvegia 4
PS - Palestinian Territory 4
Totale 30.597
Città #
Singapore 1.611
Moscow 1.403
Ashburn 1.334
Southend 1.154
San Jose 1.083
Dallas 1.032
Chandler 945
Verona 828
Hong Kong 790
Council Bluffs 502
Beijing 453
Dublin 434
The Dalles 423
New York 339
Jacksonville 251
Ann Arbor 213
Los Angeles 209
Ho Chi Minh City 198
Woodbridge 183
Munich 175
Hanoi 144
Lawrence 134
Princeton 134
Santa Clara 132
Wilmington 130
Jinan 123
Houston 117
Buffalo 111
São Paulo 107
Redondo Beach 99
Nanjing 93
Helsinki 89
Shenyang 88
Milan 87
Redmond 87
Columbus 83
Dong Ket 82
London 77
Tokyo 72
Nuremberg 66
Sindelfingen 66
Hebei 65
Orem 60
Zhengzhou 59
Seattle 57
Montreal 56
Abuja 52
Tianjin 52
Rome 51
Lomé 50
Turku 50
Amman 49
Vienna 47
Frankfurt am Main 46
Phoenix 46
Warsaw 46
Amsterdam 44
Guangzhou 44
Brussels 42
Madrid 42
Jakarta 41
Lappeenranta 41
Toronto 41
Haikou 40
Stockholm 40
Brooklyn 39
Changsha 39
Hangzhou 39
Johannesburg 39
Ningbo 38
Washington 38
Denver 36
Nanchang 36
Poplar 36
Chicago 35
Haiphong 35
Mexico City 34
Taizhou 34
Rio de Janeiro 33
Chennai 32
Cotonou 32
Jiaxing 32
Seoul 32
Brescia 31
Falkenstein 30
Redwood City 30
Taiyuan 30
Da Nang 29
Bologna 28
Manchester 28
Atlanta 27
Dearborn 27
Shanghai 27
Tashkent 26
Ankara 25
Belo Horizonte 25
Naples 25
San Francisco 25
Boardman 24
Curitiba 24
Totale 17.942
Nome #
Common Minimum Technical Standards and Protocols for Biobanks Dedicated to Cancer Research 588
MAP Kinase inhibition reshapes tumour microenvironment of mouse pancreatic cancer by depleting anti-inflammatory macrophages 304
Whole-genome landscape of pancreatic neuroendocrine tumours 286
DNA Qualification Workflow for Next Generation Sequencing of Histopathological Samples 284
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 268
Genomic characterization of hepatoid tumors: context matters 261
Genomic analyses identify molecular subtypes of pancreatic cancer 258
Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas 255
1177PUndiscovered immune heterogeneity in pancreatic adenocarcinoma (PDAC) 255
Ampulla of Vater Carcinoma: Sequencing Analysis Identifies TP53 Status as a Novel Independent Prognostic Factor and Potentially Actionable ERBB, PI3K, and WNT Pathways Gene Mutations 249
Gα15 in early onset of pancreatic ductal adenocarcinoma 243
BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing 241
The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. 233
A cross-species analysis in pancreatic neuroendocrine tumors reveals molecular subtypes with distinctive clinical, metastatic, developmental, and metabolic characteristics 229
A multimodality test to guide the management of patients with a pancreatic cyst 222
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups 220
CD200 expression is a feature of solid pseudopapillary neoplasms of the pancreas 219
"Pure" hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms 219
RON is not a prognostic marker for resectable pancreatic cancer 215
Long-Term Survivor of Intrahepatic Cholangiocarcinoma for over 18 Years: Case Study with Longitudinal Histo-molecular and Tumor Immune Microenvironment Characterization and Systematic Review of the Literature 214
IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutation 211
Disabled homolog 2 controls pro-metastatic activity of tumor-associated macrophages 210
Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer 208
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 206
Sex differences in oncogenic mutational processes 206
Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate Cancer 204
Acinar Cystic Transformation of the Pancreas: Histomorphology and Molecular Analysis to Unravel its Heterogeneous Nature 203
Ampulla of Vater carcinoma: Molecular landscape and clinical implications 203
428OImmune landscape of pancreatic neuroendocrine tumours (PanNETs) 202
Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients 201
PD-1, PD-L1 and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications 200
Colorectal cancer with microsatellite instability: Right-sided location and signet ring cell histology are associated with nodal metastases, and extranodal extension influences disease-free survival 199
Molecular Analysis of an Intestinal Neuroendocrine/Non-neuroendocrine Neoplasm (MiNEN) Reveals MLH1 Methylation-driven Microsatellite Instability and a Monoclonal Origin: Diagnostic and Clinical Implications 198
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 197
A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns 196
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer 196
A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk 196
Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC 195
Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice? 195
Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation 194
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing 193
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 192
Evaluation of cell-free DNA as a biomarker for pancreatic malignancies 192
Reporting tumor molecular heterogeneity in histopathological diagnosis 192
Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms 190
Comparative Lesions Analysis Through a Targeted Sequencing Approach 190
HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer 190
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 189
Author Correction: The landscape of viral associations in human cancers 189
Lost in translation: returning germline genetic results in genome-scale cancer research 189
Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors 189
CD117 Is a Specific Marker of Intraductal Papillary Mucinous Neoplasms (IPMN) of the Pancreas, Oncocytic Subtype 188
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma 187
Divergent mutational processes distinguish hypoxic and normoxic tumours 185
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas 184
Organoid-Transplant Model Systems to Study the Effects of Obesity on the Pancreatic Carcinogenesis in vivo 183
Epithelial-mesenchymal transition in undifferentiated carcinoma of the pancreas with and without osteoclast-like giant cells 179
Gene expression profiling of lung atypical carcinoids and large cell neuroendocrine carcinomas identifies three transcriptomic subtypes with specific genomic alterations 178
Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk 177
Research capacity. Enabling the genomic revolution in Africa 175
Hypermutation In Pancreatic Cancer 175
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas 175
Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications 175
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer 175
Genetic Polymorphisms Involved in Mitochondrial Metabolism and Pancreatic Cancer Risk 175
Lung neuroendocrine tumours: deep sequencing of the four WHO histotypes reveals chromatin remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D 172
Splice variants as novel targets in pancreatic ductal adenocarcinoma 172
Combinatorial Effect of Magnetic Field and Radiotherapy in PDAC Organoids: A Pilot Study 171
CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan 171
Neutralization of NET-associated human ARG1 enhances cancer immunotherapy 169
ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance 168
Loss of FGFR4 promotes the malignant phenotype of PDAC 167
Genome-wide association study identifies an early onset pancreatic cancer risk locus 166
Integrative characterization of intraductal tubulopapillary neoplasm (ITPN) of the pancreas and associated invasive adenocarcinoma 166
Perineural Invasion is a Strong Prognostic Moderator in Ampulla of Vater Carcinoma: A Meta-analysis 165
Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors: a retrospective analysis of 110 cases 165
Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours 165
Combinatorial Effect of Magnetic Field and Radiotherapy in Pancreatic Ductal Adenocarcinoma Organoids 165
Loss of BAP1 Expression Occurs Frequently in Intrahepatic Cholangiocarcinoma 164
Exosomal miRNA signatures of pancreatic lesions 163
International network of cancer genome projects 160
Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations 160
Expression of the membrane tetraspanin claudin 18 on cancer cells promotes T lymphocyte infiltration and antitumor immunity in pancreatic cancer 159
Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions 158
Harnessing the epigenome to boost immunotherapy response in non-small cell lung cancer patients 158
Juvenile polyposis diagnosed with an integrated histological, immunohistochemical and molecular approach identifying new SMAD4 pathogenic variants 158
Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater. 157
A Model of Collaboration ad Experiences between Bio-industry and Academic Biobanks 157
A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer 156
Alternative lengthening of telomeres (ALT) influences survival in soft tissue sarcomas: a systematic review with meta-analysis 156
Pan-cancer analysis of whole genomes 156
Genetic Analysis of Small Well-differentiated Pancreatic Neuroendocrine Tumors Identifies Subgroups With Differing Risks of Liver Metastases 156
Genomic characterization of undifferentiated sarcomatoid carcinoma of the pancreas 155
KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities 154
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples 153
Mucinous cystic neoplasms and simple mucinous cysts are two distinct precursors of pancreatic cancer: clinicopathological, genomic, and transcriptomic characterization 152
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes 151
Biosampling and biobanking (Chapter7) 151
Histo-molecular characterization of pancreatic cancer with microsatellite instability: intra-tumor heterogeneity, B2M inactivation, and the importance of metastatic sites 151
Long-term organoid culture of a small intestinal neuroendocrine tumor 150
Totale 19.506
Categoria #
all - tutte 107.708
article - articoli 102.224
book - libri 1.251
conference - conferenze 1.379
curatela - curatele 0
other - altro 1.212
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.642
Totale 215.416


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.191 0 354 75 114 52 33 54 90 51 32 81 255
2022/20232.624 160 320 203 439 219 619 45 165 291 35 89 39
2023/20241.877 57 124 125 168 177 330 95 192 56 129 305 119
2024/20255.563 298 285 329 815 309 299 429 340 704 346 522 887
2025/202615.304 1.058 735 1.147 2.330 3.522 957 1.336 873 1.319 908 534 585
2026/2027560 213 347 0 0 0 0 0 0 0 0 0 0
Totale 31.181